Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Biomarin Pharmaceutical (BMRN) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 41 quarters since 2011. Compare with BMRN stock chart to see long term trends.

BMRN stock compared to

BMRN Income Statement

Revenue, Net:486030000
Revenue Per Share:2.66
Cost of Goods & Services Sold:120166000
Selling, General & Admin Expense:174318000
Research & Development Expense:148725000
Total Operating Expenses:460944000
Operating Income:25086000
Income Taxes:5857000
Net Income:17371000
Earnings Per Share, Basic:0.1
Shares Outstanding, Basic Avg:182742573

BMRN Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:27983000
Change in Accounts Receiveable:-40294000
Net Cash from Operations:113512000
Net Cash from Financing Activities:-24364000
Property, Plant & Equipment Purchases:25507000
Net Cash from Investing Activities:-70788000
Net Change in Cash & Equivalents:18155000

BMRN Balance Sheet

Cash and Cash Equivalents:667313000
Accounts Receivable, Net:396097000
Inventories:713929000
Total Current Assets:2288766000
Property, Plant & Equipment, Net:1022474000
Total Assets:5805053000
Total Short-Term Liabilities:430035000
Total Liabilities:1643043000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Primecap Management Co/Ca/
18,191,541 sh
307,570 sh
2%
$1,384,012
-$821,797
Vanguard Group Inc
16,335,436 sh
-583,115 sh
-3%
$1,242,801
-$843,933
Blackrock Inc.
14,635,522 sh
-1,328,289 sh
-8%
$1,113,472
-$855,505
Dodge & Cox
7,720,223 sh
4,104,483 sh
114%
$587,355
$141,390
Ameriprise Financial Inc
3,006,160 sh
-127,540 sh
-4%
$228,559
-$157,992
UBS Asset Management Americas Inc
2,017,564 sh
848,740 sh
73%
$153,496,269
$9,333,517
Price T Rowe Associates Inc /Md/
1,955,282 sh
515,857 sh
36%
$148,758
-$28,781
Bank Of America Corp /De/
1,879,906 sh
1,774,906 sh
1690%
$143,024
$130,073
Goldman Sachs Group Inc
1,682,073 sh
1,604,573 sh
2070%
$127,972
$118,413
Northern Trust Corp
1,220,919 sh
-73,890 sh
-6%
$92,888
-$66,814
Legal & General Group Plc
1,126,237 sh
-5,345 sh
0%
$85,683
-$53,884
Frontier Capital Management Co LLC
958,982 sh
204,917 sh
27%
$72,959
-$20,047
Charles Schwab Investment Management Inc
682,437 sh
60,022 sh
10%
$51,921
-$24,848
FMR LLC
668,139 sh
-1,315,019 sh
-66%
$50,832
-$193,771
Voya Investment Management LLC
604,138 sh
-647,917 sh
-52%
$45,964
-$108,465
Invesco Ltd.
586,660 sh
45,748 sh
8%
$44,634
-$22,083
Morgan Stanley
521,133 sh
-51,593 sh
-9%
$39,647
-$30,992
Credit Suisse Ag/
452,354 sh
17,642 sh
4%
$34,414
-$19,202
Fred Alger Management, LLC
379,843 sh
-853,768 sh
-69%
$28,898
-$123,256
AXA
365,002 sh
-81,035 sh
-18%
$27,770
-$27,244

Data imported from Biomarin Pharmaceutical Inc SEC filings. Check original filings before making any investment decision.